Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Oklo has materially improved its execution evidence: the Groves test reactor reached first criticality less than a year after groundbreaking, Aurora-INL obtained both DOE preliminary-safety approval and NRC approval of its principal design criteria, and Meta is providing commercial support for a planned 1.2 GW Ohio campus. The investment case nevertheless remains highly dependent on completing authorization, converting fuel and customer arrangements into executable contracts, and moving from test-reactor milestones to reliable commercial power operations. The balance of demonstrated progress and still-substantial schedule risk supports a Hold rather than a directional Buy or Sell.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets20 analysts · as of 18 Aug 2026
Low · most bearish analyst$14.00
Mean target$79.88
High · most bullish analyst$130.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$14.0024%

Aurora-INL moves beyond 2028, the HALEU arrangement is not converted or deliveries slip beyond 2029, and the Ohio first phase moves beyond 2030. Under this outcome, Groves and regulatory milestones fail to translate into timely commercial power generation, causing a substantial reassessment of deployment value.

Base CaseCentral scenario
$79.8858%
Matches the consensus mean

Aurora-INL continues through authorization and construction with manageable schedule pressure, while the Meta agreement and planned domestic fuel supply preserve long-term deployment potential. Commercial power execution remains unproven, limiting valuation expansion.

Bull CaseUpside scenario
$130.0018%

Aurora-INL enters commercial operation by early 2028, the Centrus arrangement becomes definitive with 2029 deliveries intact, and the Meta-supported Ohio first phase remains on course for 2030. Groves' rapid path to criticality proves transferable to larger projects, materially lowering perceived execution risk.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Groves reached first criticality less than a year after groundbreaking, providing tangible evidence of nuclear-project execution under the DOE Reactor Pilot Program.
  • Aurora-INL received DOE approval of its preliminary safety analysis, while the NRC approved Aurora's principal design criteria for use in future applications.
  • Meta's agreement provides a funding mechanism for early development and fuel procurement supporting a planned 1.2 GW Ohio power campus.
Sign in / Sign up to read more
Key Investment Risks
  • Aurora-INL remains dependent on additional authorization and construction execution; preliminary-safety and design-criteria approvals are not equivalent to commercial operating approval.
  • The Centrus HALEU arrangement is a letter of intent that anticipates negotiation of a future definitive agreement.
  • The Ohio project is long-dated, with its first phase targeted as early as 2030 and expansion to the full 1.2 GW contemplated by 2034.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.